Explore the vast range of titles available.

\"Artificial Intelligence for Behavioural Science is a concise introduction to emerging concepts and ideas found at the intersection of contemporary behavioural science and artificial intelligence. The book explores how these disciplines interact, change and adapt to one another, and what the implications of such an interaction are for practice and society. The book begins by exploring the field of machine behaviour, which advocates using behavioural science to investigate artificial intelligence. This perspective is built upon to develop a framework of terminology which treats humans and machines as comparable entities possessive of their own motive power. From here, the notion of artificial intelligence systems becoming choice architects is explored through a series of reconceptualisations. The architecting of choices is reconceptualised as a process of selection from a set of choice architectural designs, while human behaviour is reconceptualised in terms of probabilistic outcomes. The material difference between so-called 'manual nudging' and 'automatic nudging' (or hypernudging) is then explored. The book concludes with a discussion of who is responsible for autonomous choice architects. Stuart Mills is a behavioural economist with a background in economics and political economy. His research focuses on nudge theory, personalisation, and digital economy. He is interested in the intersection of technology, data and behavioural science within public policy and finance, as well as the wider political economy implications\"-- Provided by publisher.

The use of mesenchymal stem cells (MSC) for the treatment of cutaneous wounds is currently of enormous interest. However, the broad translation of cell therapies into clinical use is hampered by their efficacy, safety, manufacturing and cost. MSCs release a broad repertoire of trophic factors and immunomodulatory cytokines, referred to as the MSC secretome, that has considerable potential for the treatment of cutaneous wounds as a cell-free therapy. In this review, we outline the current status of MSCs as a treatment for cutaneous wounds and introduce the potential of the MSC secretome as a cell-free alternative for wound repair. We discuss the challenges and provide insights and perspectives for the future development of the MSC secretome as well as identify its potential clinical translation into a therapeutic treatment.

Much of current research investigates the beneficial properties of mesenchymal stem cells (MSCs) as a treatment for wounds and other forms of injury. In this review, we bring attention to and discuss the role of the pericyte, a cell type which shares much of the differentiation potential and regenerative properties of the MSC as well as specific roles in the regulation of angiogenesis, inflammation and fibrosis. Pericytes have been identified as dysfunctional or depleted in many disease states, and observing the outcomes of pericyte perturbation in models of disease and wound healing informs our understanding of overall pericyte function and identifies these cells as an important target in the development of therapies to encourage healing.

New guidelines for the nomenclature of polymorphs and polysomes have been approved by the the Commission on New Minerals, Nomenclature and Classification of the International Mineralogical Association (IMA-CNMNC). Several cases can be distinguished. (i) Polymorphs with different crystal systems are distinguished by the prefixes cubo- (cubic), hexa- (hexagonal), tetra- (tetragonal), trigo- (trigonal), ortho- (orthorhombic), clino- (monoclinic) and anortho- (triclinic). (ii) Polymorphs with different crystal systems but showing a pseudosymmetry should show the prefix 'pseudo-'. (iii) Polymorphs with the same crystal system but different space groups are distinguished by the prefix 'para-'. If three or more polymorphs show the same crystal system but different space groups, the space group notation may be added as a suffix, though such a nomenclature should be avoided if possible. (iv) Polymorphs with the same space group are distinguished by the prefix 'para-'. (v) Minerals with polymorph suffixes but with different chemical compositions cannot be considered as true polymorphs, so we recommend using the prefix 'meta-', which indicates a close but significantly different chemical composition. (vi) Polysomatic symbols should be placed as a suffix, which indicates the number and types of modules that alternate in the structure, such as in the högbomite supergroup, or as prefixes as in the sartorite homologous series. These recommendations have to be applied for future new mineral proposals, when the authors decide to use structural prefixes or suffixes, however modifications of historical and well-established names have to pass through the CNMNC for approval. In order to be consistent with the new guidelines, 25 mineral names are now modified: domeykite-β becomes trigodomeykite; fergusonite-(Y)-β becomes clinofergusonite-(Y); fergusonite-(Ce)-β becomes clinofergusonite-(Ce); fergusonite-(Nd)-β becomes clinofergusonite-(Nd); ice-VII becomes cubo-ice; roselite-β becomes anorthoroselite; sulphur-β becomes clinosulphur; mertieite-II becomes mertieite; mertieite-I becomes pseudomertieite; uranophane-α becomes uranophane; uranophane-β becomes parauranophane; gersdorffite-P213 becomes gersdorffite; gersdorffite-Pa3 becomes paragersdorffite; gersdorffite-Pca21 becomes orthogersdorffite; betalomonosovite becomes paralomonosovite; lammerite-β becomes paralammerite; novácekite-I becomes hydronovácekite; novácekite-II becomes novácekite; halloysite-7Å becomes halloysite; halloysite-10Å becomes hydrohalloysite; metauranocircite-I becomes metauranocircite; taimyrite-I becomes taimyrite; uranocircite-II becomes uranocircite; andorite IV becomes quatrandorite; and andorite VI becomes senandorite.